Exagen (XGN) Equity Ratio (2018 - 2026)

Exagen (XGN) has reported Equity Ratio for 9 consecutive years, with 0.28 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.28, up 74.8% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.28 (up 74.8% YoY), and the FY2025 annual result was 0.3, up 40.87% from the prior year.
• Equity Ratio was 0.28 for Q1 2026 at Exagen, down from 0.3 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.62 in Q1 2022 and troughed at 0.16 in Q1 2025.
• Average Equity Ratio over 5 years is 0.39, with a median of 0.39 recorded in 2024.
• Year-over-year, Equity Ratio tumbled 59.61% in 2025 and jumped 74.8% in 2026.
• Over 5 years, Equity Ratio stood at 0.49 in 2022, then dropped by 19.07% to 0.4 in 2023, then plunged by 46.43% to 0.21 in 2024, then soared by 40.87% to 0.3 in 2025, then slipped by 7.64% to 0.28 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.28 in Q1 2026, 0.3 in Q4 2025, and 0.29 in Q3 2025.